Conference Reports for NATAP

The Liver Meeting San Francisco November 2018 Back

Economic Burden of Progression to Cirrhosis in Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States       Reported by Jules Levin AASLD 2018 Nov 9-13 SF   Dhaval Patil,1 Ying Qiu,1 Tzuyung D. Kou,1 Joel Myers,1 Aditya Nandal,2 Leah Burns1 1Bristol-Myers Squibb, Princeton, New Jersey; 2Mu-Sigma, Bangalore, India   Rising and Higher Healthcare Resource Utilization (HCRU) and Costs of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease of Increasing Severity - Results of a US Real-World Analysis - (11/16/18)   Fatty Liver/NASH/NAFLD at AASLD   AASLD The Liver Meeting Washington DC San Francisco November 9-13 2018   AASLD: The Incidence of Malignancies in Nonalcoholic Fatty Liver Disease - (12/11/18)   AASLD: The Worldwide Prevalence of Non-alcoholic Steatohepatitis (NASH) in Patients with Type 2 Diabetes Mellitus (DM) - (12/10/18)